[Long-term controlled clinical trial of a new anti-anginal drug].
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D001161:Arteriosclerosis / Q000188:drug therapy*; D001663:Bilirubin / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy*; D004906:Erythrocyte Count; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D000637:Transaminases / Q000097:blood; D014665:Vasodilator Agents / Q000627:therapeutic use*
D001798:Blood Proteins; D010879:Piperazines; D014665:Vasodilator Agents; D002784:Cholesterol; D000637:Transaminases; D005996:Nitroglycerin; D001663:Bilirubin
Sperimentazione clinica controllata a lungo termine di un nuovo farmaco antianginoso.